Use of preferentially replicating bacteria for the treatment of cancer
AUTOR(ES)
Sznol, Mario
FONTE
American Society for Clinical Investigation
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=300839Documentos Relacionados
- Immunomodulation of cancer: potential use of selectively replicating agents
- Topoisomerase I is preferentially associated with isolated replicating simian virus 40 molecules after treatment of infected cells with camptothecin.
- Conditionally replicating herpes vectors for cancer therapy
- Kinetic suppression of microtubule dynamic instability by griseofulvin: Implications for its possible use in the treatment of cancer
- Use of Aminoglycosides in Treatment of Infections Due to Intracellular Bacteria